BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12368965)

  • 1. Changes in early-onset group B beta hemolytic streptococcus disease with changing recommendations for prophylaxis.
    Uy IP; D'Angio CT; Menegus M; Guillet R
    J Perinatol; 2002; 22(7):516-22. PubMed ID: 12368965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-onset group B streptococcal disease in the era of maternal screening.
    Puopolo KM; Madoff LC; Eichenwald EC
    Pediatrics; 2005 May; 115(5):1240-6. PubMed ID: 15867030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of a group B streptococcus prevention policy at a community hospital.
    Clemens CJ; Gable EK
    J Perinatol; 2002; 22(7):523-5. PubMed ID: 12368966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continued early onset group B streptococcal infections in the era of intrapartum prophylaxis.
    Pulver LS; Hopfenbeck MM; Young PC; Stoddard GJ; Korgenski K; Daly J; Byington CL
    J Perinatol; 2009 Jan; 29(1):20-5. PubMed ID: 18704032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems.
    Pinto NM; Soskolne EI; Pearlman MD; Faix RG
    J Perinatol; 2003 Jun; 23(4):265-71. PubMed ID: 12774131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a strategy to prevent neonatal early-onset group B streptococcal (GBS) sepsis.
    Renner RM; Renner A; Schmid S; Hoesli I; Nars P; Holzgreve W; Surbek DV
    J Perinat Med; 2006; 34(1):32-8. PubMed ID: 16489884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of perinatal group B streptococcal disease in Minnesota: results from a retrospective cohort study and new prevention guidelines.
    Ogunmodede F; Virnig BA; Danila R; Lynfield R
    Minn Med; 2003 Aug; 86(8):40-5. PubMed ID: 12959179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perinatal group B streptococcal disease after universal screening recommendations--United States, 2003-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Jul; 56(28):701-5. PubMed ID: 17637595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.
    Schrag SJ; Zywicki S; Farley MM; Reingold AL; Harrison LH; Lefkowitz LB; Hadler JL; Danila R; Cieslak PR; Schuchat A
    N Engl J Med; 2000 Jan; 342(1):15-20. PubMed ID: 10620644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal group B streptococcus infection, neonatal outcome and the role of preventive strategies.
    Elvedi-Gasparović V; Peter B
    Coll Antropol; 2008 Mar; 32(1):147-51. PubMed ID: 18494200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminishing racial disparities in early-onset neonatal group B streptococcal disease--United States, 2000-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jun; 53(23):502-5. PubMed ID: 15201842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-onset and late-onset neonatal group B streptococcal disease--United States, 1996-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Dec; 54(47):1205-8. PubMed ID: 16319814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Institution of universal screening for Group B streptococcus (GBS) from a risk management protocol results in reduction of early-onset GBS disease in a tertiary obstetric unit.
    Angstetra D; Ferguson J; Giles WB
    Aust N Z J Obstet Gynaecol; 2007 Oct; 47(5):378-82. PubMed ID: 17877594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of universal maternal screening on the incidence of neonatal early-onset group B streptococcal disease.
    Eberly MD; Rajnik M
    Clin Pediatr (Phila); 2009 May; 48(4):369-75. PubMed ID: 18832528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of early-onset Group B Streptococcal disease - the Northern Ireland experience.
    Eastwood KA; Craig S; Sidhu H; Boyle M; Gannon C; Ong G; Lupari M; Craven A; Magowan S; Ashe RG
    BJOG; 2015 Feb; 122(3):361-7. PubMed ID: 24861487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease.
    Lin FY; Brenner RA; Johnson YR; Azimi PH; Philips JB; Regan JA; Clark P; Weisman LE; Rhoads GG; Kong F; Clemens JD
    Am J Obstet Gynecol; 2001 May; 184(6):1204-10. PubMed ID: 11349189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis.
    Jordan HT; Farley MM; Craig A; Mohle-Boetani J; Harrison LH; Petit S; Lynfield R; Thomas A; Zansky S; Gershman K; Albanese BA; Schaffner W; Schrag SJ;
    Pediatr Infect Dis J; 2008 Dec; 27(12):1057-64. PubMed ID: 18989238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with ampicillin-resistant infection in newborns in the era of group B streptococcal prophylaxis.
    Rentz AC; Samore MH; Stoddard GJ; Faix RG; Byington CL
    Arch Pediatr Adolesc Med; 2004 Jun; 158(6):556-60. PubMed ID: 15184219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No increase in rates of early-onset neonatal sepsis by antibiotic-resistant group B Streptococcus in the era of intrapartum antibiotic prophylaxis.
    Chen KT; Puopolo KM; Eichenwald EC; Onderdonk AB; Lieberman E
    Am J Obstet Gynecol; 2005 Apr; 192(4):1167-71. PubMed ID: 15846197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group B streptococcus late-onset disease: 2003-2010.
    Berardi A; Rossi C; Lugli L; Creti R; Bacchi Reggiani ML; Lanari M; Memo L; Pedna MF; Venturelli C; Perrone E; Ciccia M; Tridapalli E; Piepoli M; Contiero R; Ferrari F;
    Pediatrics; 2013 Feb; 131(2):e361-8. PubMed ID: 23296441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.